Therapeutics Goods Administration

MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

MARIETTA, Ga., Aug. 9, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced…